NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
James Yu
Yale University - New Haven / United States
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 846747
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
James Yu's MOST POPULAR ARTICLES
1-)
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trialSB Goldberg, SN Gettinger, A Mahajan, AC Chiang, RS Herbst, M Sznol, ...The lancet oncology 17 (7), 976-983, 20168942016
2-)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus documentY Lievens, M Guckenberger, D Gomez, M Hoyer, P Iyengar, I Kindts, ...Radiotherapy and Oncology 148, 157-166, 20204822020
3-)
Management of brain metastases in tyrosine kinase inhibitor–naïve epidermal growth factor receptor–mutant non–small-cell lung cancer: a retrospective multi-institutional analysisWJ Magnuson, NH Lester-Coll, AJ Wu, TJ Yang, NA Lockney, NK Gerber, ...Journal of clinical oncology 35 (10), 1070-1077, 20174692017
4-)
A retrospective review of 1349 cases of sebaceous carcinomaT Dasgupta, LD Wilson, JB YuCancer 115 (1), 158-165, 20094182009
5-)
Use of alternative medicine for cancer and its impact on survivalSB Johnson, HS Park, CP Gross, JB YuJNCI: Journal of the National Cancer Institute 110 (1), 121-124, 20183712018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept